Click for best price
Diagnostic Radiopharmaceuticals & Contrast Media Market Size, Share 2022
Market Analysis and Insights: Global Diagnostic Radiopharmaceuticals & Contrast Media Market
The global Diagnostic Radiopharmaceuticals & Contrast Media market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Diagnostic Radiopharmaceuticals & Contrast Media market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Diagnostic Radiopharmaceuticals & Contrast Media market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Diagnostic Radiopharmaceuticals & Contrast Media market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Diagnostic Radiopharmaceuticals & Contrast Media market.
Global Diagnostic Radiopharmaceuticals & Contrast Media Scope and Market Size
Diagnostic Radiopharmaceuticals & Contrast Media market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Diagnostic Radiopharmaceuticals & Contrast Media market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Radiopharmaceuticals
Contrast Media
Segment by Application
Hospital
Clinic
Other
By Company
Amag Pharmaceuticals
Bayer Healthcare
Bracco Imaging
Daiichi Sankyo
GE Healthcare
Guerbet
Lantheus
Mallinckrodt
Medtronic
Nordion
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Diagnostic Radiopharmaceuticals & Contrast Media product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Diagnostic Radiopharmaceuticals & Contrast Media, with price, sales, revenue, and global market share of Diagnostic Radiopharmaceuticals & Contrast Media from 2019 to 2022.
Chapter 3, the Diagnostic Radiopharmaceuticals & Contrast Media competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Diagnostic Radiopharmaceuticals & Contrast Media breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Diagnostic Radiopharmaceuticals & Contrast Media market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Diagnostic Radiopharmaceuticals & Contrast Media.
Chapter 13, 14, and 15, to describe Diagnostic Radiopharmaceuticals & Contrast Media sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Diagnostic Radiopharmaceuticals & Contrast Media Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global Diagnostic Radiopharmaceuticals & Contrast Media Market Insights, Forecast to 2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
108 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Diagnostic Radiopharmaceuticals & Contrast Media Product Introduction
1.2 Market by Type
1.2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Radiopharmaceuticals
1.2.3 Contrast Media
1.3 Market by Application
1.3.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Estimates and Forecasts 2017-2028
2.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Estimates and Forecasts 2017-2028
2.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region
2.4.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region (2017-2022)
2.4.2 Global Sales Diagnostic Radiopharmaceuticals & Contrast Media by Region (2023-2028)
2.5 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region
2.5.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region (2017-2022)
2.5.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Manufacturers
3.1.1 Global Top Diagnostic Radiopharmaceuticals & Contrast Media Manufacturers by Sales (2017-2022)
3.1.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Diagnostic Radiopharmaceuticals & Contrast Media in 2021
3.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Manufacturers
3.2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Manufacturers (2017-2022)
3.2.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Diagnostic Radiopharmaceuticals & Contrast Media Revenue in 2021
3.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type
4.1.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Historical Sales by Type (2017-2022)
4.1.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Forecasted Sales by Type (2023-2028)
4.1.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Type (2017-2028)
4.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Type
4.2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Historical Revenue by Type (2017-2022)
4.2.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Forecasted Revenue by Type (2023-2028)
4.2.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Type (2017-2028)
4.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Price by Type
4.3.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Price by Type (2017-2022)
4.3.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application
5.1.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Historical Sales by Application (2017-2022)
5.1.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Forecasted Sales by Application (2023-2028)
5.1.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Application (2017-2028)
5.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application
5.2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Historical Revenue by Application (2017-2022)
5.2.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Forecasted Revenue by Application (2023-2028)
5.2.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Application (2017-2028)
5.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Price by Application
5.3.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Price by Application (2017-2022)
5.3.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Price Forecast by Application (2023-2028)
6 North America
6.1 North America Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Type
6.1.1 North America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2017-2028)
6.1.2 North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Type (2017-2028)
6.2 North America Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Application
6.2.1 North America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2017-2028)
6.2.2 North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application (2017-2028)
6.3 North America Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Country
6.3.1 North America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2017-2028)
6.3.2 North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Type
7.1.1 Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2017-2028)
7.1.2 Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Type (2017-2028)
7.2 Europe Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Application
7.2.1 Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2017-2028)
7.2.2 Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application (2017-2028)
7.3 Europe Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Country
7.3.1 Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2017-2028)
7.3.2 Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Type
8.1.1 Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2017-2028)
8.1.2 Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Type (2017-2028)
8.2 Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Application
8.2.1 Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2017-2028)
8.2.2 Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application (2017-2028)
8.3 Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Region
8.3.1 Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region (2017-2028)
8.3.2 Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Type
9.1.1 Latin America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2017-2028)
9.1.2 Latin America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Type (2017-2028)
9.2 Latin America Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Application
9.2.1 Latin America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2017-2028)
9.2.2 Latin America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application (2017-2028)
9.3 Latin America Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Country
9.3.1 Latin America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2017-2028)
9.3.2 Latin America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Type
10.1.1 Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2017-2028)
10.1.2 Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Type (2017-2028)
10.2 Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Application
10.2.1 Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2017-2028)
10.2.2 Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application (2017-2028)
10.3 Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Country
10.3.1 Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2017-2028)
10.3.2 Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Amag Pharmaceuticals
11.1.1 Amag Pharmaceuticals Corporation Information
11.1.2 Amag Pharmaceuticals Overview
11.1.3 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Amag Pharmaceuticals Recent Developments
11.2 Bayer Healthcare
11.2.1 Bayer Healthcare Corporation Information
11.2.2 Bayer Healthcare Overview
11.2.3 Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bayer Healthcare Recent Developments
11.3 Bracco Imaging
11.3.1 Bracco Imaging Corporation Information
11.3.2 Bracco Imaging Overview
11.3.3 Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bracco Imaging Recent Developments
11.4 Daiichi Sankyo
11.4.1 Daiichi Sankyo Corporation Information
11.4.2 Daiichi Sankyo Overview
11.4.3 Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Daiichi Sankyo Recent Developments
11.5 GE Healthcare
11.5.1 GE Healthcare Corporation Information
11.5.2 GE Healthcare Overview
11.5.3 GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GE Healthcare Recent Developments
11.6 Guerbet
11.6.1 Guerbet Corporation Information
11.6.2 Guerbet Overview
11.6.3 Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Guerbet Recent Developments
11.7 Lantheus
11.7.1 Lantheus Corporation Information
11.7.2 Lantheus Overview
11.7.3 Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Lantheus Recent Developments
11.8 Mallinckrodt
11.8.1 Mallinckrodt Corporation Information
11.8.2 Mallinckrodt Overview
11.8.3 Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Mallinckrodt Recent Developments
11.9 Medtronic
11.9.1 Medtronic Corporation Information
11.9.2 Medtronic Overview
11.9.3 Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Medtronic Recent Developments
11.10 Nordion
11.10.1 Nordion Corporation Information
11.10.2 Nordion Overview
11.10.3 Nordion Diagnostic Radiopharmaceuticals & Contrast Media Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Nordion Diagnostic Radiopharmaceuticals & Contrast Media Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Nordion Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Diagnostic Radiopharmaceuticals & Contrast Media Industry Chain Analysis
12.2 Diagnostic Radiopharmaceuticals & Contrast Media Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Diagnostic Radiopharmaceuticals & Contrast Media Production Mode & Process
12.4 Diagnostic Radiopharmaceuticals & Contrast Media Sales and Marketing
12.4.1 Diagnostic Radiopharmaceuticals & Contrast Media Sales Channels
12.4.2 Diagnostic Radiopharmaceuticals & Contrast Media Distributors
12.5 Diagnostic Radiopharmaceuticals & Contrast Media Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Diagnostic Radiopharmaceuticals & Contrast Media Industry Trends
13.2 Diagnostic Radiopharmaceuticals & Contrast Media Market Drivers
13.3 Diagnostic Radiopharmaceuticals & Contrast Media Market Challenges
13.4 Diagnostic Radiopharmaceuticals & Contrast Media Market Restraints
14 Key Findings in The Global Diagnostic Radiopharmaceuticals & Contrast Media Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Radiopharmaceuticals
Table 3. Major Manufacturers of Contrast Media
Table 4. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region (2017-2022) & (K Units)
Table 7. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Region (2017-2022)
Table 8. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region (2023-2028) & (K Units)
Table 9. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Region (2023-2028)
Table 10. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Region (2017-2022)
Table 12. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Region (2023-2028)
Table 14. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Share by Manufacturers (2017-2022)
Table 16. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Share by Manufacturers (2017-2022)
Table 18. Diagnostic Radiopharmaceuticals & Contrast Media Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Diagnostic Radiopharmaceuticals & Contrast Media Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Diagnostic Radiopharmaceuticals & Contrast Media by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Radiopharmaceuticals & Contrast Media as of 2021)
Table 21. Diagnostic Radiopharmaceuticals & Contrast Media Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Diagnostic Radiopharmaceuticals & Contrast Media Product Offered
Table 23. Date of Manufacturers Enter into Diagnostic Radiopharmaceuticals & Contrast Media Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2017-2022) & (K Units)
Table 26. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2023-2028) & (K Units)
Table 27. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Share by Type (2017-2022)
Table 28. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Share by Type (2023-2028)
Table 29. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Share by Type (2017-2022)
Table 32. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Share by Type (2023-2028)
Table 33. Diagnostic Radiopharmaceuticals & Contrast Media Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Diagnostic Radiopharmaceuticals & Contrast Media Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2017-2022) & (K Units)
Table 36. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2023-2028) & (K Units)
Table 37. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Share by Application (2017-2022)
Table 38. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Share by Application (2023-2028)
Table 39. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Share by Application (2017-2022)
Table 42. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Share by Application (2023-2028)
Table 43. Diagnostic Radiopharmaceuticals & Contrast Media Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Diagnostic Radiopharmaceuticals & Contrast Media Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2017-2022) & (K Units)
Table 46. North America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2023-2028) & (K Units)
Table 47. North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2017-2022) & (K Units)
Table 50. North America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2023-2028) & (K Units)
Table 51. North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2017-2022) & (K Units)
Table 54. North America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2023-2028) & (K Units)
Table 55. North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2017-2022) & (K Units)
Table 58. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2023-2028) & (K Units)
Table 59. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2017-2022) & (K Units)
Table 62. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2023-2028) & (K Units)
Table 63. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2017-2022) & (K Units)
Table 66. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2023-2028) & (K Units)
Table 67. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2023-2028) & (US$ Million)
Table 105. Amag Pharmaceuticals Corporation Information
Table 106. Amag Pharmaceuticals Description and Major Businesses
Table 107. Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Amag Pharmaceuticals Recent Developments
Table 110. Bayer Healthcare Corporation Information
Table 111. Bayer Healthcare Description and Major Businesses
Table 112. Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Bayer Healthcare Recent Developments
Table 115. Bracco Imaging Corporation Information
Table 116. Bracco Imaging Description and Major Businesses
Table 117. Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Bracco Imaging Recent Developments
Table 120. Daiichi Sankyo Corporation Information
Table 121. Daiichi Sankyo Description and Major Businesses
Table 122. Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Daiichi Sankyo Recent Developments
Table 125. GE Healthcare Corporation Information
Table 126. GE Healthcare Description and Major Businesses
Table 127. GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. GE Healthcare Recent Developments
Table 130. Guerbet Corporation Information
Table 131. Guerbet Description and Major Businesses
Table 132. Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Guerbet Recent Developments
Table 135. Lantheus Corporation Information
Table 136. Lantheus Description and Major Businesses
Table 137. Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Lantheus Recent Developments
Table 140. Mallinckrodt Corporation Information
Table 141. Mallinckrodt Description and Major Businesses
Table 142. Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 143. Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Mallinckrodt Recent Developments
Table 145. Medtronic Corporation Information
Table 146. Medtronic Description and Major Businesses
Table 147. Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 148. Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Medtronic Recent Developments
Table 150. Nordion Corporation Information
Table 151. Nordion Description and Major Businesses
Table 152. Nordion Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 153. Nordion Diagnostic Radiopharmaceuticals & Contrast Media Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Nordion Recent Developments
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Diagnostic Radiopharmaceuticals & Contrast Media Distributors List
Table 158. Diagnostic Radiopharmaceuticals & Contrast Media Customers List
Table 159. Diagnostic Radiopharmaceuticals & Contrast Media Market Trends
Table 160. Diagnostic Radiopharmaceuticals & Contrast Media Market Drivers
Table 161. Diagnostic Radiopharmaceuticals & Contrast Media Market Challenges
Table 162. Diagnostic Radiopharmaceuticals & Contrast Media Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Diagnostic Radiopharmaceuticals & Contrast Media Product Picture
Figure 3. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Type in 2021 & 2028
Figure 3. Radiopharmaceuticals Product Picture
Figure 4. Contrast Media Product Picture
Figure 5. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Application in 2021 & 2028
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Other
Figure 9. Diagnostic Radiopharmaceuticals & Contrast Media Report Years Considered
Figure 10. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales 2017-2028 (K Units)
Figure 11. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue 2017-2028 (US$ Million)
Figure 13. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Region (2017-2022)
Figure 15. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Region (2023-2028)
Figure 16. North America Diagnostic Radiopharmaceuticals & Contrast Media Sales YoY (2017-2028) & (K Units)
Figure 17. North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales YoY (2017-2028) & (K Units)
Figure 19. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales YoY (2017-2028) & (K Units)
Figure 21. Asia-Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Diagnostic Radiopharmaceuticals & Contrast Media Sales YoY (2017-2028) & (K Units)
Figure 23. Latin America Diagnostic Radiopharmaceuticals & Contrast Media Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales YoY (2017-2028) & (K Units)
Figure 25. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Diagnostic Radiopharmaceuticals & Contrast Media Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Diagnostic Radiopharmaceuticals & Contrast Media in the World: Market Share by Diagnostic Radiopharmaceuticals & Contrast Media Revenue in 2021
Figure 28. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Type (2017-2028)
Figure 30. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Type (2017-2028)
Figure 31. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Application (2017-2028)
Figure 32. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Application (2017-2028)
Figure 33. North America Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Type (2017-2028)
Figure 34. North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Type (2017-2028)
Figure 35. North America Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Application (2017-2028)
Figure 36. North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Application (2017-2028)
Figure 37. North America Diagnostic Radiopharmaceuticals & Contrast Media Sales Share by Country (2017-2028)
Figure 38. North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue Share by Country (2017-2028)
Figure 39. U.S. Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Type (2017-2028)
Figure 42. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Type (2017-2028)
Figure 43. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Application (2017-2028)
Figure 44. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Application (2017-2028)
Figure 45. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales Share by Country (2017-2028)
Figure 46. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue Share by Country (2017-2028)
Figure 47. Germany Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2017-2028) & (US$ Million)
Figure 48. France Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue Share by Region (2017-2028)
Figure 58. China Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2017-2028) & (US$ Million)
Figure 61. India Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2017-2028) & (US$ Million)
Figure 63. Taiwan Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2017-2028) & (US$ Million)
Figure 67. Philippines Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Type (2017-2028)
Figure 69. Latin America Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Application (2017-2028)
Figure 71. Latin America Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Diagnostic Radiopharmaceuticals & Contrast Media Sales Share by Country (2017-2028)
Figure 73. Latin America Diagnostic Radiopharmaceuticals & Contrast Media Revenue Share by Country (2017-2028)
Figure 74. Mexico Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue Share by Country (2017-2028)
Figure 83. Turkey Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Diagnostic Radiopharmaceuticals & Contrast Media Revenue (2017-2028) & (US$ Million)
Figure 86. Diagnostic Radiopharmaceuticals & Contrast Media Value Chain
Figure 87. Diagnostic Radiopharmaceuticals & Contrast Media Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
